🚨 Don't miss your final chance to join us at the #BayOConnect event in Munich, where Dr. Eduardo Beltrán will be a part of the panel discussion on July 3 at 14:45 CET titled "You Never Walk Alone - Leveraging Added Value with Data and AI". ✨ Key highlights: 🔹 Transforming #biotech companies through partnerships with BC Platforms 🔹 Real-world examples of sophisticated data management integration 🔹 Utilizing #AI to streamline processes, accelerate research, and enhance biotech collaboration 🔗 Discover more and get your ticket: https://lnkd.in/gtV8eyZc #GenomicData #BayOConnect2024 #DataScience #Healthcare #LifeSciences #AI4Medicine #AI4Health #AI4Biotech #bigdata
Info
BC Platforms is a global leader in Real-World Data, Technology Platforms and Services. We build data networks for life science and provide versatile technology platforms for personalised medicine, accelerating the translation of innovations into clinical practice. We convert complex biological information collected in the healthcare setting into actionable insights. With our innovative technology we are creating a patient centric infinity loop between the life sciences and healthcare sectors. Data we generate, harmonise, and manage, from diverse biobanks and healthcare institutions, is made accessible for pharmaceutical and biotech companies to enhance their core strengths in research and development. In parallel, we enable stratification of patients towards targeted therapies, delivering on the promise of more personalized healthcare. Our high performing genomic data discovery and analytics platform enables flexible data integration, secure analysis, and interpretation of molecular and clinical information. We have developed a Global Data Partner Network, BCRQUEST.com, which allows access to high-quality real-world data. This rapidly growing network has a footprint across many sites, including networks of major hospitals, covering 20+ countries in five continents, providing patient data for over 70 million patients. Our platforms seamlessly facilitate access to highly enriched data for pharmaceutical research and development. Founded in 1997 from a MIT Whitehead project spinoff, we have a strong scientific heritage underpinned by over 26 years of working in close collaboration with a network of leading researchers, developers, and industry partners. We have global operations with our headquarters in Zurich, Switzerland, R&D in Espoo, Finland, and Singapore, as well as a presence in London, UK, Lund, Sweden, Toulouse, France and Boston, USA. For more information, please visit www.bcplatforms.com.
- Website
-
http://www.bcplatforms.com
Externer Link zu BC Platforms
- Branche
- Softwareentwicklung
- Größe
- 51–200 Beschäftigte
- Hauptsitz
- Zurich, Zurich
- Art
- Privatunternehmen
- Gegründet
- 1997
- Spezialgebiete
- bioinformatics, clinical data management, data integration, Precision Medicine, genomics, real world data, data networks, genomic and clinical data management, secure data environments, trusted research environments, real world evidence, health technology, platforms, scientific services, genomics, data security & privacy, health data und genomics workstreams and infrastructure
Orte
Beschäftigte von BC Platforms
Updates
-
We're thrilled to see our team's poster on the "BC Platforms' Systematic Approach to OMOP Oncology Federated Query and Analytical Solutions in ONCOVALUE consortium" featured at #OHDSIEurope2024. Big thanks to Mai Nguyen, and Inka Lehtonen, Kalle Pärn, Mark Heffernan, Anni Ahonen-Bishopp, HANG PHAN. #OHDSISocialShowcase #OncologyResearch #CancerResearch #OMOP
BC Platforms' Systematic Approach to OMOP Oncology Federated Query and Analytical Solutions in ONCOVALUE consortium #OHDSISocialShowcase #OHDSIEurope2024 Lead: Mai Nguyen, PhD Team: Sinka Lehtonen, Kalle Pärn, Mark Heffernan, Anni Ahonen-Bishopp, Hang T.T. Phan #JoinTheJourney
-
-
Today is #FattyLiverDay and June is #FattyLiverMonth! BC Platforms/Medexprim is proud to be a founding partner of ARTEMIs - The Power of Virtual Twins to Fight MASLD. Leveraging the power of 21 partners from 9 countries, #VirtualTwins, a Cutting-Edge Clinical Decision Support System (#CDSS), and an interactive Visualization Tool, #ARTEMIs is poised to transform the diagnosis and treatment of Metabolic dysfunction-associated fatty liver disease (#MASLD). Thank you to all our partners for their dedication and collaboration! Cristina d'Almeida Laure Saint-Aubert Laura Muñoz Senovilla EU Health and Food Safety World Health Organization WHO Regional Office for Europe Cliniques universitaires Saint-Luc European Liver Patients' Association - ELPA Bournemouth University Imperial College London AP-HP, Assistance Publique - Hôpitaux de Paris IHU ICAN Medical Research Institute La Fe (IIS La Fe) Hospital Universitari Vall d'Hebron MATICAL INNOVATION Sheba Medical Center, Tel Hashomer, Charité - Universitätsmedizin Berlin Albert-Ludwigs-Universität Freiburg Universität Leipzig DKFZ German Cancer Research Center Betthera Medizinische Universität Wien Sapienza Università di Roma
Embark on a Journey with ARTEMIs: A Revolution in Fatty Liver Disease Management! Today is #FattyLiverDay and this month is #FattyLiverMonth! Let's raise awareness and take action together! This year, we proudly launch #ARTEMIs, an EU-funded marvel destined to redefine the landscape of Metabolic dysfunction-associated fatty liver disease (#MASLD). Officially inaugurated on January 1st, ARTEMIs is a visionary initiative that aims to transform the approach to Europe's leading chronic liver disease, now surpassing viral hepatitis and alcohol-related causes. -🔬 What Sets ARTEMIs Apart? - Liver & Heart Virtual Twins: Advanced simulations to personalize patient care. Cutting-Edge Clinical Decision Support System (CDSS): Empowering clinicians with real-time insights. Interactive Visualization Tool Simplifying risk stratification and early diagnosis predictions for 7500 patients across 9 nations. 🌐 ARTEMIs Kick-Off Celebration! From the heart of Paris, a groundbreaking mission unfolds with 21 formidable partners, each contributing to a tapestry of innovation and hope. As we stand at this transformative crossroads, the ARTEMIs consortium embraces a shared ambition – to redefine the healthcare landscape for Fatty Liver Patients globally. Join us in this extraordinary endeavor to accelerate the translation of virtual twins into a personalized triumph over the complexities of MASLD! Together, we amplify our strength, proving that unity knows no borders. 🤝💪 🇪🇺 Meet Our Amazing Partners: EU Health and Food Safety WHO Regional Office for Europe Medexprim Cliniques universitaires Saint-Luc European Liver Patients' Association - ELPA Bournemouth University Imperial College London Greater Paris University Hospitals - AP-HP IHU ICAN (IIS La Fe) Hospital Universitari Vall d'Hebron | MATICAL INNOVATION Sheba Medical Center, Tel Hashomer, Sheba Medical Center, Tel Hashomer | Charité - Universitätsmedizin Berlin Heidelberg University The University of Freiburg Leipzig University DKFZ German Cancer Research Center Betthera | Medical University of Vienna Sapienza Università di Roma Join the Revolution! Follow Our Journey #ARTEMISHealthcareRevolution #TogetherStronger Stay Informed #Innovation #Data #ClinicalTrials #HorizonEurope #PersonalizedMedicine #RealWorldData Witness the dawn of a new era in healthcare! The ARTEMIs initiative is a groundbreaking effort to combat #FattyLiverDiseases by uniting clinicians, modelers, patients, and regulators to pioneer personalized medicine tools. With a regulatory-grade #MASLD cohort, Liver & Heart Virtual Twins, and a user-friendly smart dashboard, ARTEMIS is poised to lead the charge against Fatty Liver Diseases. 💪 Let's revolutionize healthcare together!** #HealthcareInnovation #MedicalResearch #PersonalizedMedicine EASL the home of Hepatology Vlad Ratziu Raluca Pais Irene Vignon-Clementel Cristina d'Almeida Mario Aznar
-
-
🌟Today Nino da Silva, Managing Director APAC at BC Platforms, was invited as a guest speaker at #PacBioPRISM 2024 - a #GenomicsResearch and #Innovation #Event - to present on #TrustedResearchEnvironments / #SecureDataEnvironments. The presentation gave an overview of the evolution of our solution to a world leading #TRE / #SDE utilized in #lifescience and #healthcare worldwide, consolidating and managing multimodal #omics and #clinical #data, and exemplifying by use cases from around the world with emphasis in #APAC and the work being conducted there. PacBio 📸 Charlie Lee, PhD
-
-
We had an incredible time at the OHDSI (Observational Health Data Sciences & Informatics) Symposium, where our Data Scientist team, Mai Nguyen and Kalle Pärn, presented their posters on "Advancing Value-Based Cancer Care" through the #ONCOVALUE project and "Enhancing Healthcare Insights." Thank you to everyone who stopped by and engaged with us at #OHDSI! 🔗 Discover BC Platforms' solution offering a #SecureDataEnvironment for #MultimodalResearch, enabling integrated analysis of diverse data types, including #ClinicalData, #genomics, #proteomics, and #imaging. Learn more here: https://bit.ly/3Kvns4M ❓ Do you have a question? Contact our experts: https://bit.ly/4bHoGWB #OHDSIEurope2024 #SDE #OMOP #EHDEN #RWD #HealthcareInnovation #Oncology #Research
-
-
📣 Are you onboard #OHDSI June 1-3? 📣 We are attending the upcoming OHDSI (Observational Health Data Sciences & Informatics) Symposium! Aligned with OHDSI's mission, we are dedicated to advancing research by transforming #RealWorldData into actionable intelligence that drives better health outcomes. Don't miss our Data Scientist team, Mai Nguyen and Kalle Pärn, and explore our two posters to learn more about our efforts in "Advancing Value-Based Cancer Care" through the #ONCOVALUE project and "Enhancing Healthcare Insights" by empowering informed decision-making. 🔗 Discover BC Platforms' complete solution empowering your #DataManagement, #analytics, and insights: https://bit.ly/3VjIaLj ❓ Interested in learning more? Contact our experts: https://bit.ly/3VkKqSo #OHDSIEurope2024 #OMOP #EHDEN #RWD #HealthcareInnovation #Oncology #Research
-
-
BC Platforms hat dies direkt geteilt
When selecting our investments, we prioritise the themes outlined in our strategy. Health & life sciences is one of these themes and encompasses companies that innovate and develop solutions for health problems and improve quality of lives. 🧬🔬 Operating in the intersection of global pharmaceutical industry and healthcare, BC Platforms is a great example of such a company from our portfolio! Watch the short video below and see what BC Platforms does, exactly. 👇 You can also read more in a case article: https://lnkd.in/dv6YagJm #HealthandLifeSciences #HealthTech #VentureCapital #GrowthEquity
-
🌟 Transforming Oncology with Real-World Data 🌟 Learn how BC Platforms helps revolutionize #CancerResearch and #CancerCare through the power of #RealWorldData (RWD). Discover how our globally sourced and analysis-ready oncology data can support your research to accelerate innovation and #DrugDevelopment. 🔗 Learn more here: https://bit.ly/45001dq ✨ Meet us in Chicago at #ASCO2024 to hear how our data can empower your organization's fight against #cancer: https://bit.ly/3yyDVTb #Oncology #RWD #RealWorldEvidence #EHR #NSCLC #lymphoma #leukemia #ASCO24 #PrecisionMedicine #pharma
-
-
🚀 We're thrilled to announce that Mikaela Bruhammar ♦️, Interim CEO, will be speaking at the upcoming AWS Healthcare & Life Sciences Day during the AWS for Industries Week in Zurich! 🚀 About Mikaela's Session: 📣 Topic: #SecureDataEnvironments in #Healthcare 📅 Date: Thursday, May 23 ⏰ Time: 15:35 CET 📍 Location: Zurich Mikaela will dive deep into how BC Platforms, a leader in Health Tech for over 25 years, enables seamless and secure data environments for #clinical, #genomic, and #ImagingData. Learn how our solutions empower researchers and analysts to: 🔷 Conduct feasibility analysis across datasets 🔷 Request access to specific cohorts for defined purposes 🔷 Utilize their preferred analytics packages within a secure environment Don’t miss out on this opportunity to meet with Mikaela Bruhammar ♦️ and Alex Ide to explore the future of healthcare innovation: https://bit.ly/3yveUs6! 🌟 #AWS #AWSforIndustries #PoweringInnovation #Healthcare #LifeSciences #AWSSwitzerland #HealthcareInnovation #DataPrivacy #GenerativeAI #DigitalTransformation #SDE #HealthTech
-
-
🚀 Our team is heading to #ASCO24! 🚀 Join Mikaela Bruhammar ♦️, Kaj Työppönen, Weston Fox, and Alexandre Blanchot, Pharm.D at the forefront of oncology research. With a global oncology #RealWorldData footprint spanning North America, Europe, and Asia, we provide unparalleled insights and solutions. Schedule a meeting with our experts to discuss how our #RWD solutions and extensive experience in #oncology can support your innovation in #CancerResearch and #CancerCare. 👉 Schedule your meeting with us here: https://bit.ly/4atI87R We look forward to engaging in insightful discussions and forming valuable collaborations at ASCO! 🔬 Discover how our expertise in oncology can empower your organization's efforts in accelerating progress against #cancer. Download our #RWD Availability Snapshot: https://bit.ly/4bGEyZL #ASCO2024 #DrugDevelopment #RareDiseases #PrecisionMedicine #pharma
-
Ähnliche Seiten
Finanzierung
BC Platforms
Insgesamt 4 Finanzierungsrunden
![]()
Jolt Capital
Letzte Runde
Privates Eigenkapital
Externer Crunchbase-Link für die letzte Finanzierungsrunde
20.312.673,00 $
Investor:innen